According to Zhitong Finance App, Qingcheng New Pharmaceutical-B (02396) announced that the company and Dongfang Finance (Hong Kong) Co., Ltd. signed a termination agreement on October 15, 2026 due to internal business evaluation and commercial considerations. The two parties agreed to terminate the current compliance advisory agreement between the company and Oriental Finance, which will take effect from October 15, 2026.

New Berry Finance Co., Ltd. has been appointed as the company's new compliance advisor in accordance with section 3A.27 of the listing rules, effective from October 15, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.